These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24266509)

  • 1. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application.
    Dasgupta S; Ghosh SK; Ray S; Kaurav SS; Mazumder B
    Curr Drug Deliv; 2014; 11(1):132-8. PubMed ID: 24266509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
    Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
    AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
    El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
    Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.
    Dasgupta S; Dey S; Choudhury S; Mazumder B
    Expert Opin Drug Deliv; 2013 Apr; 10(4):411-20. PubMed ID: 23316798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
    Shakeel F; Ramadan W; Ahmed MA
    J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
    Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
    Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.
    El-Leithy ES; Makky AM; Khattab AM; Hussein DG
    Drug Dev Ind Pharm; 2018 Feb; 44(2):316-328. PubMed ID: 29096550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
    Li K; Gao S; Tian B; Shi Y; Lv Q; Han J
    Curr Drug Deliv; 2018; 15(3):424-435. PubMed ID: 29219057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
    Kumar D; Ali J; Baboota S
    Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
    Al-Mahallawi AM; Abdelbary AA; Aburahma MH
    Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
    Shahzad Y; Khan Q; Hussain T; Shah SN
    Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
    Sharma S; Sahni JK; Ali J; Baboota S
    Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
    Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
    Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
    Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
    Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system.
    Esmaeili F; Rajabnejhad S; Partoazar AR; Mehr SE; Faridi-Majidi R; Sahebgharani M; Syedmoradi L; Rajabnejhad MR; Amani A
    Pharm Dev Technol; 2016 Nov; 21(7):887-893. PubMed ID: 26365132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
    Kumbhar D; Wavikar P; Vavia P
    AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A QUALITY BY DESIGN APPROACH: FABRICATION, CHARACTERIZATION AND EVALUATION OF OPTIMIZED TRANSDERMAL THERAPEUTIC SYSTEM FOR ANTIRHEUMATIC LORNOXICAM.
    Naeem M; Pervaiz F; Nawaz Z; Yousup M; Ali A; Khalid N; Khan JA
    Acta Pol Pharm; 2017 Jan; 74(1):249-266. PubMed ID: 29474780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.